Washington: American biotech company Moderna is going to bring its Corona vaccine to market soon. In the US, 30 thousand volunteers are participating in the third phase trial of mRNA-1273 vaccine. But it has had a negative impact on a volunteer. The Volunteer of the University of North Carolina has complained of pain and fever after taking the first dose of Moderna’s vaccine.
A Volunteer named Jack Morningstar told an American news channel, “I have experienced some side effects after taking the first injection. The next day I was feeling a bit tired and had a fever. Also some at the injection site There was pain too. “
However, the volunteer has also urged people to take this vaccine of Moderna. Jack Morningstar said, “I don’t think we should be intimidated by low-grade fever and a little bit of pain. It’s nothing. I understand that if you also get the opportunity, whether clinical trials or once in public. Everyone should take this vaccine if it is available. Because it is ultimately saving life and we will get some rest beforehand. “
Moderna in preparation for global launch of vaccine
American company Moderna announced that it is preparing for the global launch of its Kovid-19 vaccine. In a statement, Moderna CEO Stephen Bansell said, “We are actively preparing for the launch of mRNA-1273 and we have signed several supply agreements with governments around the world.”
According to Banksel, in addition to the Phase III study of the COVID-19 vaccine mRNA-1273, Moderna now has four Phase II programs. Moderna is committed to the highest data quality standards and rigorous scientific research.
Let me tell you, on October 22, the third phase study of mRNA-1273 completed the enrollment on 30,000 participants with about 37 percent participants from diverse communities.
read this also-
Yoga Guru Baba Ramdev claims – Coronil is not a immunity booster, but is a medicine for corona virus
Diwali’s glory faded during the Corona period, epidemic halves shopkeepers